These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 16276140)
1. Nesiritide for pulmonary arterial hypertension with decompensated cor pulmonale. Kingman MS; Thompson BS; Newkirk T; Torres F Prog Cardiovasc Nurs; 2005; 20(4):168-72. PubMed ID: 16276140 [TBL] [Abstract][Full Text] [Related]
2. Nesiritide for the treatment of pulmonary hypertension and cor pulmonale in an infant. Reynolds EW; Conely ET; Vranicar M Pediatr Cardiol; 2007; 28(3):229-33. PubMed ID: 17375350 [TBL] [Abstract][Full Text] [Related]
3. Nesiritide: the latest drug for treating heart failure. Fontana D Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809 [No Abstract] [Full Text] [Related]
4. Use of nesiritide to treat acute decompensated heart failure. Hachey DM; Smith T Crit Care Nurse; 2003 Feb; 23(1):53-5. PubMed ID: 12640959 [No Abstract] [Full Text] [Related]
5. Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure. O'Dell KM; Kalus JS; Kucukarslan S; Czerska B Am J Health Syst Pharm; 2005 Mar; 62(6):606-9. PubMed ID: 15757881 [TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension. Michaels AD; Chatterjee K; De Marco T J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633 [TBL] [Abstract][Full Text] [Related]
8. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790 [TBL] [Abstract][Full Text] [Related]
9. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure. Yancy CW Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969 [TBL] [Abstract][Full Text] [Related]
10. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers. Abraham WT; Cheng ML; Smoluk G; Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969 [TBL] [Abstract][Full Text] [Related]
11. A comparison of nesiritide vs. epoprostenol in a patient with precapillary pulmonary hypertension due to scleroderma complicated by postcapillary pulmonary hypertension. Zakir RM; Berkowitz RL; Saric M; Ashtyani H Congest Heart Fail; 2005; 11(6):331-4. PubMed ID: 16330910 [TBL] [Abstract][Full Text] [Related]
12. Concomitant use of nesiritide and milrinone in decompensated congestive heart failure. Smull DL; Jorde UP Am J Health Syst Pharm; 2005 Feb; 62(3):291-5. PubMed ID: 15719588 [No Abstract] [Full Text] [Related]
13. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential. Burger MR; Burger AJ Curr Opin Investig Drugs; 2001 Jul; 2(7):929-35. PubMed ID: 11757793 [TBL] [Abstract][Full Text] [Related]